Drugs / MT400
last change Dec 2007 re-read 2 minutes ago

MT400

Investigated by
GlaxoSmithKline · POZEN

Trials 1 · a red edge is where a trial was stopped

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00596245 Oct → Dec 2007 GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as MT 400 “Open-Label, Placebo-Controlled, Parallel Group Study in Healthy Volunteers to Evaluate the Effects of Two Single MT 400 or Naproxen Sodium Tablets” NCT00596245
1

“Drug: MT400” NCT00596245